医学分子生物学杂志 ›› 2024, Vol. 21 ›› Issue (2): 146-153.doi: 10.3870/j.issn.1672-8009.2024.02.009

• 论著 • 上一篇    下一篇

白藜芦醇抑制肾纤维化减轻单侧输尿管梗阻诱导的肾损伤 #br#


  

  1. 重庆市大足区人民医院血透室 重庆市, 402360
  • 出版日期:2024-03-31 发布日期:2024-04-29
  • 基金资助:
    重庆市大足区科技发展项目 (No. DZKJ2023JSYJ-KWXM1031)

Resveratrol Inhibits Renal Fibrosis and Reduces Kidney Damage Caused by Unilateral Ureteral Obstruction #br#

  1. Hemodialysis RoomChongqing Dazu District People’ s HospitalChongqing402360China
  • Online:2024-03-31 Published:2024-04-29

摘要: 目的 研究白藜芦醇抑制肾纤维化对单侧输尿管梗阻诱导的肾损伤的减轻作用及相关机制 方法 Sprague-Dawley (SD) 大鼠和成纤维细胞 NRK-49F 为实验对象, 分别进行体内研究和体外验证, 体内: SD 大鼠行单侧输尿管梗阻诱导建立 TIF 大鼠模型, 将大鼠随机分为 4 (假手术 + 空白组假手术 +白藜芦醇组模型 + 空白组和模型 + 白藜芦醇组), 每组 12 只大鼠体外: NRK-49F 细胞用重组 TGF- β1 (5 ng / mL) 或白藜芦醇 (10 100 μmol / L) 处理后随机分为 4 (对照组、 TGF-β1 、 TGF-β1 + 白藜芦醇低剂量组和 TGF-β1 + 白藜芦醇高剂量组)。 Masson’ s 染色检测肾脏中总胶原蛋白沉积; 免疫组织化学染色检测组织中 E-cadherin、 GFAP Ki67 阳性细胞的表达; 免疫荧光染色检测细胞中 Ki67 阳性细胞的表达; 蛋白质印迹检测组织中 E-cadherin、 Vimentin、 N-cadherin、 Rac1、 c-Myc、 Bcl-2、 Cyclin D1、 α-SMA、Ⅰ 型胶原和型胶原的表达结果 与对照组比较, 白藜芦醇可以抑制大鼠体内单侧输尿管梗阻 ( unilateral ureteral obstruction, UUO) 肾脏中总胶原蛋白的过度沉积, 下调 α-SMA 阳性成肌纤维细胞减少波形蛋白、Ⅰ 型和型胶原, 抑制 Rac1、 GFAP N-cadherin 的上调以及 E-cadherin 的下调; 与假手术组比较, 白藜芦醇可显著降低 UUO 大鼠中 Ki67 阳性细胞比率, 并抑制 c-Myc, Bcl-2 cyclin D1 的表达; 白藜芦醇抑制体内增殖相关途径 Wnt / β-catenin 的激活; 体外实验表明白藜芦醇治疗可减少成纤维细胞和 TECs 的增殖,

而抑制 TGF-β1 介导的表型转化和 ECM 积累 结论成肌纤维细胞的积累, 并减轻了肾小管间质纤维化 白藜芦醇通过抑制 Wnt / β-catenin 通路的活性, 抑制

关键词:

慢性肾病, 白藜芦醇, 单侧输尿管梗阻, 肾小管间质纤维化, 细胞外基质, Wnt / β-catenin 通路

Abstract: Objective To investigate the effect of resveratrol on renal fibrosis and kidney damage induced by unilateral ureteral obstruction and its related mechanism. Methods  Sprague-dawley( SD) rats and NRK-49F fibroblasts were used as experimental subjects for in vivo study and in vitrovalidation. In vivo, TIF rat model was establish by surgery to induce the unilateral ureteral obstruction in SD rats, and the rats were then randomly divided into 4 groups: sham operation + blankgroup, sham operation + resveratrol group, model + blank group and model + resveratrol group, 12rats in each group. In vitro: NRK-49F cells were treated with recombinant TGF-β1 (5 ng / mL) orresveratrol (10 and 100 μmol / L) and randomly divided into 4 groups: control group, TGF-β1 group, TGF-β1 + resveratrol low-dose group and TGF-β + resveratrol high-dose group. Masson’ s staining was used to detect total collagen deposition in the kidney. Immunohistochemical staining was used to detect the expression of E-cadherin, GFAP and Ki67 in the tissues. Immunofluorescence staining was used to detect the expression of Ki67 in cells. Western blotting was used to detect the expression level of Vimentin, N-cadherin, Racl, c-Myc, Bcl-2, Cyclin D1, α-SMA, type I collagen and type Ⅲ collagen, E-cadherin. Results Resveratrol could inhibit the excessive depositionof total collagen in kidneys of UUO rats, down-regulate α-SMA-positive myofibroblasts, reduce the expression of vimentin, type I and type Ⅲ collagen, and inhibit the up-regulation of Rac1, GFAP and down-regulation of N-cadherin. Resveratrol could significantly reduce the ratio of Ki67-positive cells in UUO rats and inhibit the expression level of c-Myc, Bcl-2 and cyclin D1. Resveratrol inhibited the activation of proliferation-related pathway Wnt / β-catenin. The in vitro experimentsshowedthat resveratrol treatment could reduce the proliferation of fibroblasts and TECs, thereby inhibiting

TGF-β1-mediated phenotypic transformation and ECM accumulation. Conclusion Resveratrol in
hibits the activity of Wnt / β-catenin pathway and the accumulation of myofibroblasts, and reduces
renal tubulointerstitial fibrosis.


Key words:

chronic kidney disease, resveratrol, unilateral ureteral obstruction, renal tubule
interstitial fibrosis, extracellular matrix, Wnt / β-catenin pathway

中图分类号: